FIELD: medicine, pharmacy. SUBSTANCE: pharmaceutical coposition has tumor necrosis alpha-factor, hyaluronic acid, dimethylsulfoxide and polyethylene oxide in the following ratio of components, wt.-%: tumor necrosis alpha-factor, 0.001-0.01; hyaluronic acid, 0.1-1.0; dimethylsulfoxide, 5.0-15.0 and polyethylene oxide, the balance. Composition is used for treatment of infection-inflammatory diseases, among them in complex therapy of acute and chronic gynecological inflammatory diseases, in complex therapy of herpetic and other viral infections, in treatment of urogenital infections and in treatment of sluggish wounds. EFFECT: enhanced therapeutic effectiveness, broadened spectrum of use. 1 cl, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBACTERIAL AND NECROLYTIC EXTERNAL AND LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367457C2 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2351322C1 |
| ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION ON BASIS OF LOW-MOLECULAR INDUCTOR OF INTERFERON | 2007 |
|
RU2352330C1 |
| LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
| ANTIBACTERIAL AND NECROLYTIC LOCAL PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367456C2 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
| PHARMACEUTICAL COMPOSITION FOR LOCAL AND EXTERNAL APPLICATION WHEN TREATING TRAUMATIC AND POST-OPERATION INJURIES OF PERIPHERAL NERVOUS SYSTEM | 2007 |
|
RU2369387C2 |
| PHARMACEUTICAL COMPOSITION FOR LOCAL AND EXTERNAL APPLICATION WHEN TREATING TRAUMATIC AND POST-OPERATION INJURIES OF PERIPHERAL NERVOUS SYSTEM | 2007 |
|
RU2369388C2 |
| WOUND-HEALING MEANS | 2017 |
|
RU2644255C1 |
